113 related articles for article (PubMed ID: 38871390)
1. Interreader and Intrareader Reproducibility of
Kuo PH; Esposito G; Ulaner GA; Yoo D; Zukotynski K; Ravizzini GC; Penny R; Miller MP; Chau A; Davis P; Chapin BF; Schuster DM;
J Nucl Med; 2024 Jun; ():. PubMed ID: 38871390
[TBL] [Abstract][Full Text] [Related]
2. A VISION Substudy of Reader Agreement on
Kuo PH; Yoo DC; Avery R; Seltzer M; Calais J; Nagarajah J; Weber WA; Fendler WP; Hofman MS; Krause BJ; Brackman M; Kpamegan E; Ghebremariam S; Benson T; Catafau AM; Kendi AT
J Nucl Med; 2023 Aug; 64(8):1259-1265. PubMed ID: 37230533
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 3 Interpretation Criteria for
Toriihara A; Nobashi T; Baratto L; Duan H; Moradi F; Park S; Hatami N; Aparici CM; Davidzon G; Iagaru A
J Nucl Med; 2020 Apr; 61(4):533-539. PubMed ID: 31562226
[TBL] [Abstract][Full Text] [Related]
4. True-Positive
Fleming MT; Hermsen R; Purysko AS; Chau A; Davis P; Chapin BF; Schuster DM
J Nucl Med; 2024 May; ():. PubMed ID: 38782456
[No Abstract] [Full Text] [Related]
5. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using
Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P
J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791
[No Abstract] [Full Text] [Related]
6. Quantitative and Qualitative Assessment of Urinary Activity of
Kuo PH; Hermsen R; Penny R; Postema EJ
Mol Imaging Biol; 2024 Feb; 26(1):53-60. PubMed ID: 37932609
[TBL] [Abstract][Full Text] [Related]
7. Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Grawe F; Blom F; Winkelmann M; Burgard C; Schmid-Tannwald C; Unterrainer LM; Sheikh GT; Pfitzinger PL; Kazmierczak P; Cyran CC; Ricke J; Stief CG; Bartenstein P; Ruebenthaler J; Fabritius MP; Geyer T
Eur Radiol; 2024 Feb; 34(2):1157-1166. PubMed ID: 37624414
[TBL] [Abstract][Full Text] [Related]
8. Interreader agreement in evaluation of 68Ga-PSMA PET/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups.
Karahan Şen NP; Aksu A; Bozkurt O; Tuna EB; Çapa Kaya G
Nucl Med Commun; 2022 Jan; 43(1):86-91. PubMed ID: 34559761
[TBL] [Abstract][Full Text] [Related]
9. Added Value of [18F]PSMA-1007 PET/CT and PET/MRI in Patients With Biochemically Recurrent Prostate Cancer: Impact on Detection Rates and Clinical Management.
Abrahamsen BS; Tandstad T; Aksnessæther BY; Bogsrud TV; Castillejo M; Hernes E; Johansen H; Keil TMI; Knudtsen IS; Langørgen S; Selnæs KM; Bathen TF; Elschot M
J Magn Reson Imaging; 2024 Apr; ():. PubMed ID: 38679841
[TBL] [Abstract][Full Text] [Related]
10. Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.
Hope TA; Benz M; Jiang F; Thompson D; Barbato F; Juarez R; Hernandez Pampaloni M; Allen-Auerbach M; Gupta P; Fendler WP; Calais J
J Nucl Med; 2023 Nov; 64(11):1744-1747. PubMed ID: 37591547
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
12. Matched-Pair Comparison of
Wondergem M; van der Zant FM; Broos WAM; Knol RJJ
J Nucl Med; 2021 Oct; 62(10):1422-1429. PubMed ID: 33547211
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study.
Hagens MJ; Oprea-Lager DE; Vis AN; Wondergem M; Donswijk ML; Meijer D; Emmett L; van Leeuwen PJ; van der Poel HG
J Nucl Med; 2022 Oct; 63(10):1531-1536. PubMed ID: 36008118
[TBL] [Abstract][Full Text] [Related]
14. Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.
Partovi S; Kohan A; Vercher-Conejero JL; Rubbert C; Margevicius S; Schluchter MD; Gaeta C; Faulhaber P; Robbin MR
AJNR Am J Neuroradiol; 2014 Oct; 35(10):1970-5. PubMed ID: 24924545
[TBL] [Abstract][Full Text] [Related]
15. Effects of Changes in BI-RADS Density Assessment Guidelines (Fourth Versus Fifth Edition) on Breast Density Assessment: Intra- and Interreader Agreements and Density Distribution.
Irshad A; Leddy R; Ackerman S; Cluver A; Pavic D; Abid A; Lewis MC
AJR Am J Roentgenol; 2016 Dec; 207(6):1366-1371. PubMed ID: 27656766
[TBL] [Abstract][Full Text] [Related]
16.
Fendler WP; Calais J; Allen-Auerbach M; Bluemel C; Eberhardt N; Emmett L; Gupta P; Hartenbach M; Hope TA; Okamoto S; Pfob CH; Pöppel TD; Rischpler C; Schwarzenböck S; Stebner V; Unterrainer M; Zacho HD; Maurer T; Gratzke C; Crispin A; Czernin J; Herrmann K; Eiber M
J Nucl Med; 2017 Oct; 58(10):1617-1623. PubMed ID: 28408531
[TBL] [Abstract][Full Text] [Related]
17. Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.
Fendler WP; Calais J; Eiber M; Flavell RR; Mishoe A; Feng FY; Nguyen HG; Reiter RE; Rettig MB; Okamoto S; Emmett L; Zacho HD; Ilhan H; Wetter A; Rischpler C; Schoder H; Burger IA; Gartmann J; Smith R; Small EJ; Slavik R; Carroll PR; Herrmann K; Czernin J; Hope TA
JAMA Oncol; 2019 Jun; 5(6):856-863. PubMed ID: 30920593
[TBL] [Abstract][Full Text] [Related]
18.
Mei R; Kessler L; Pabst KM; Weber M; Schmidkonz C; Rischpler C; Zacho HD; Hope T; Schwarzenböck SM; Allen-Auerbach M; Emmett L; Ferdinandus J; Unterrainer M; Schaarschmidt BM; Umutlu L; Farolfi A; Castellucci P; Nanni C; Telo S; Fanti S; Herrmann K; Fendler WP
J Nucl Med; 2023 Jul; 64(7):1043-1048. PubMed ID: 37230530
[No Abstract] [Full Text] [Related]
19. aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in
Nickols N; Anand A; Johnsson K; Brynolfsson J; Borreli P; Parikh N; Juarez J; Jafari L; Eiber M; Rettig M
J Nucl Med; 2022 Feb; 63(2):233-239. PubMed ID: 34049980
[TBL] [Abstract][Full Text] [Related]
20. Whole-body Magnetic Resonance Imaging in Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls: Interscan, Intrareader, and Interreader Agreement and Distribution of Lesions.
Poulsen AEF; Axelsen MB; Poggenborg RP; Eshed I; Krabbe S; Glinatsi D; Møller JM; Østergaard M
J Rheumatol; 2021 Feb; 48(2):198-206. PubMed ID: 32541078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
